Advanced search×

Recurrence and long-term maternal health risks of hypertensive disorders of pregnancy: a population-based study.

Alice B AB Andersgaard, Ganesh G Acharya, Ellisiv B EB Mathiesen, Stein H SH Johnsen, Bjørn B Straume, and Pål P Øian

Am J Obstet Gynecol 206(2):143.e1-8 (2012) PMID 22036665

The purpose of this study was to investigate the recurrence risk of hypertensive disorders in subsequent pregnancies and to explore the associations among hypertensive disorders of pregnancy and maternal cardiovascular risk factor profile and the development of cardiovascular diseases later in life.

Copyright © 2011 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.ajog.2011.09.032
Version: za2963e q8za0 q8zbe q8zc1 q8zdf q8zea q8zfc q8zg9
Buy PDF

Similar articles you may find interesting…

  1. Trends in the medical management of patients with heart failure.
    Samuel W Joffe, Matthew Dewolf, and Robert J Goldberg

    J Clin Med Res 5(3):194-204 (2013) PMID 23671545

    We reviewed the medical records of 9,748 residents of the Worcester, MA, metropolitan area who were hospitalized with ADHF at all 11 central Massachusetts medical centers in 1995, 2000, 2002, and 2004. Between 1995 and 2004, respectively, the prescription upon hospital discharge of b...
    PDF not found
  2. Sphenoid sinus fungall ball: a retrospective study over a 10- year period.
    Ph Eloy, J Grenier, and Ph Rombaux

    Rhinology 51(2):181-8 (2013) PMID 23671900

    We report the symptomatology, the imaging and discuss the different surgical managements. We conclude that the clinician must have a high index of suspicion when dealing with a unilateral rhinosinusitis persisting despite a maximal and well conducted medical treatment. This is particularly so in eld...
    Buy PDF
  3. Fracture Risk in Older, Long-Term Survivors of Early-Stage Breast Cancer.
    Pamala A Pawloski, Ann M Geiger, and Terry S Field

    J Am Geriatr Soc (2013) PMID 23647433

    No difference was observed in fracture rates between groups (hazard ratio (HR) = 1.1, 95% confidence interval (CI) = 0.9-1.3). The protective effect of tamoxifen was not statistically significant (HR = 0.9, 95% CI = 0.6-1.2). CONCLUSION: Long-term survivors of early-stage breast cancer diagn...
    Buy PDF